信息搜索
信息关键字：医
  

共有3486条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175]

·百元股数量达207只医药生物、电子、机械设备行业占比均超10%2021-11-24 17:26:47
·可孚医疗：新冠抗原检测试剂欧盟家用自测资质在申报中2021-11-24 16:53:19
·可孚医疗：新冠抗原检测试剂欧盟家用自测资质处于申报中2021-11-24 16:36:31
·复盘90涨停股：九安医疗8板正海磁材、金运激光20CM连板2021-11-24 16:24:13
·助力精准医疗创新九强生物控股子公司与普瑞基全面深化技术与应用合作2021-11-24 16:24:03
·和信投顾：指数3600点震荡白酒医药好转2021-11-24 15:16:53
·可孚医疗：新冠抗原检测试剂欧盟家用自测资质在申报中2021-11-24 15:00:23
·免费研报精选：服装家纺板块暴涨的原因找到了！医药股现在还能买吗？（附名单）2021-11-24 12:42:24
·“医药茅”拟6亿元回购；7连板九安医疗收关注函；“光伏茅”签70亿元销售合同2021-11-24 9:08:25
·29家A股公司预告全年业绩医药等行业表现抢眼2021-11-24 8:56:09
·轶德医疗股东陶燕萍增持1712.18万股权益变动后持股比例为43.47%2021-11-24 0:39:27
·美芝股份签署《南方医科大学第七附属医院和顺院区改造提升项目建设工程施工合同》合同暂定金额1.71亿2021-11-23 21:09:32
·七连板九安医疗收关注函：要求说明在互动易上就试剂盒产品的相关答复是否审慎、客观2021-11-23 20:43:56
·阳普医疗：实控人邓冠华所持1808.95万股解除质押2021-11-23 19:41:00
·美芝股份：与南方医科大学第七附属医签订1.71亿元施工合同2021-11-23 19:03:16
·互联网医疗“强监管”时代到来利好龙头企业2021-11-23 18:50:56
·华润医药入主博雅生物落地累计耗资近48亿取得40%股权2021-11-23 17:46:19
·盘后机会挖掘汇总：英洛华一字涨停！稀土概念火爆医疗器械板块异动发生了什么？2021-11-23 17:38:05
·森萱医药接待4家机构线上调研：通过调整产品售价来消化成本上升2021-11-23 17:00:17
·中瑞医药排队北交所：拟募1.45亿元全部用于补流和还贷2021-11-23 16:56:09

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175]